Anti-Müllerian hormone (AMH) is a substance produced by cells within the ovarian follicles and serves as an important marker of a woman’s ovarian reserve, which refers to the quantity of eggs remaining in her ovaries. Measuring AMH levels has become increasingly valuable in assessing female fertility potential, particularly when evaluating reasons for difficulty conceiving or planning future pregnancies. Low AMH levels often indicate a diminished ovarian reserve, meaning fewer viable eggs are available for fertilization. This decline can significantly impact fertility, especially as women age.
Ovarian reserve naturally decreases over time due to the finite number of eggs present at birth. Women are born with approximately one to two million immature eggs, but this number steadily declines throughout life until menopause occurs when egg supply is nearly exhausted. While learn more about low amh causes itself does not directly cause infertility, it reflects underlying changes that reduce the likelihood of conception. Women with low AMH may experience irregular menstrual cycles and reduced responsiveness to fertility treatments such as ovulation induction or in vitro fertilization (IVF). Consequently, identifying low AMH levels helps healthcare providers tailor treatment plans more effectively.
Several factors contribute to decreased AMH levels beyond normal aging. Genetic predispositions can influence how rapidly ovarian reserves diminish in some individuals compared to others. Medical conditions like endometriosis or autoimmune disorders might also accelerate follicular loss and lower hormone production. Additionally, certain surgeries involving the ovaries or exposure to chemotherapy and radiation therapy can damage ovarian tissue and decrease AMH concentrations significantly.
It is important to understand that while low AMH indicates fewer available eggs, it does not provide information about egg quality directly. Egg quality tends to decline with age independently from quantity; therefore, younger women with low AMH may still have good-quality eggs capable of resulting in healthy pregnancies despite a reduced count. Conversely, older women might face challenges related both to egg number and quality simultaneously.
Testing for AMH usually involves a simple blood draw performed at any point during the menstrual cycle since hormone levels remain relatively stable throughout the month compared to other reproductive hormones like follicle-stimulating hormone (FSH). Interpreting results requires considering individual circumstances including age, medical history, and reproductive goals rather than relying solely on numeric values.
In summary, low anti-Müllerian hormone levels serve as an indicator of declining ovarian reserve and play a crucial role in understanding female fertility potential. Recognizing these changes early allows for informed decision-making regarding family planning options such as attempting pregnancy sooner or exploring assisted reproductive technologies if necessary. While challenging emotionally for many women facing diminished reserves, advances in fertility medicine continue providing hope through personalized approaches based on comprehensive hormonal evaluation including measurement of AMH concentrations alongside other clinical assessments.
Head Office
168, BSNL Road, Near BSNL office, Sector 3, Hiran magri, Udaipur, Rajasthan 313001
Call
+91 90018 38800
+91 90019 97440
Email Us
[email protected]
Operating Hours
Mon – Sat 9 AM – 6 PM
Sunday 9 AM – 4 PM